ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.94
-0.08 (-1.33%)
Jun 29, 2026, 12:36 PM EDT - Market open
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $67 million as of June 29, 2026.
Market Cap
67.00M
Enterprise Value
-48.64M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.94
Market Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $67.00M, a decrease of -63.40%. That is a compound annual growth rate of -66.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 67.00M | -13.16% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 72.83M |
| Acrivon Therapeutics | 71.91M |
| XBiotech | 71.04M |
| Pliant Therapeutics | 70.05M |
| BeyondSpring | 69.49M |
| Seres Therapeutics | 68.56M |
| eXoZymes | 68.09M |
| Cingulate | 66.81M |